press release Archives - Bolt Biotherapeutics

Press Release

Bolt Biotherapeutics Prices Upsized Initial Public Offering

By Andrea Tu|2021-02-05T07:25:01-08:00February 5, 2021|press release|Comments Off

Bolt Biotherapeutics Expands Board of Directors with Appointment of Kathleen [...]

By Andrea Tu|2021-02-04T14:47:03-08:00January 3, 2021|press release|Comments Off

Bolt Biotherapeutics Presents Ongoing Clinical Trial Poster at San Antonio [...]

By Andrea Tu|2021-02-04T14:47:43-08:00December 9, 2020|press release|Comments Off

Data Published in Nature Cancer Highlight Preclinical Proof of Concept [...]

By Andrea Tu|2021-02-04T14:48:13-08:00December 7, 2020|press release|Comments Off

Bolt Biotherapeutics Presents BDC-1001 Ongoing Clinical Trial Design and Supportive [...]

By Andrea Tu|2021-01-03T21:36:16-08:00September 20, 2020|press release|Comments Off

Bolt Biotherapeutics Closes $93.5 Million Series C Financing

By Andrea Tu|2020-11-10T12:16:17-08:00August 1, 2020|press release|Comments Off

Bolt Biotherapeutics Announces Issuance of U.S. Patent for the Boltbody™ [...]

By Andrea Tu|2020-08-27T18:06:24-07:00June 9, 2020|press release|Comments Off

Bolt Biotherapeutics Appoints William P. Quinn as Chief Financial Officer

By Andrea Tu|2020-08-27T18:06:47-07:00May 12, 2020|press release|Comments Off

Bolt Biotherapeutics Appoints Edith Perez, M.D., as Chief Medical Officer

By Andrea Tu|2020-08-27T18:09:16-07:00April 9, 2020|press release|Comments Off

Bolt Biotherapeutics Appoints Nathan Ihle, Ph.D., as Vice President of [...]

By Andrea Tu|2020-08-27T18:41:50-07:00April 2, 2020|press release|Comments Off